Literature DB >> 10624365

Non-operative management of perforated duodenal ulcer.

Y A Gul1, M F Shine, F Lennon.   

Abstract

We describe the selective non-operative management of 34 patients who had an initial diagnosis of perforated duodenal ulcer made on acute presentation between 1984-1994 in our district surgical unit. Diagnosis of the condition was made on clinical grounds with the aid of an erect chest X-ray which demonstrated pneumoperitoneum in 28 patients (82 per cent). Six patients (18 per cent) who did not respond to non-operative treatment required surgical intervention; 3 patients had an unsealed duodenal ulcer perforation; 2 had a perforated benign gastric ulcer and 1 patient had acute gangrenous cholecystitis. The overall mortality and morbidity rate was 3 per cent and 35 per cent respectively. There were no documented reperforations over a mean follow-up period of 27 months. While these figures are acceptable and comparable with operative intervention for this condition, we do however stress the labour intensive methods and close clinical monitoring that is required to avoid morbid sequelae.

Entities:  

Mesh:

Year:  1999        PMID: 10624365     DOI: 10.1007/bf02944352

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  9 in total

1.  Management of perforated peptic ulcer.

Authors:  C J BERNE; W P MIKKELSEN
Journal:  Surgery       Date:  1958-09       Impact factor: 3.982

2.  Guest lecture: the nonsurgical treatment of perforated peptic ulcer.

Authors:  H TAYLOR
Journal:  Gastroenterology       Date:  1957-09       Impact factor: 22.682

3.  Nonoperative treatment of perforated peptic ulcer; a further report.

Authors:  S F SEELEY; D CAMPBELL
Journal:  Surg Gynecol Obstet       Date:  1956-05

4.  A bacteriological study of perforated duodenal ulcers.

Authors:  N Shinagawa; M Muramoto; S Sakurai; T Fukui; K Hori; M Taniguchi; K Mashita; A Mizuno; J Yura
Journal:  Jpn J Surg       Date:  1991-01

5.  Changing trends in acute peptic ulcer surgery in a district surgical unit.

Authors:  M C Barry; Y Gul; M G Davies; D Long; M F Shine; F Lennon
Journal:  Ir J Med Sci       Date:  1996 Apr-Jun       Impact factor: 1.568

6.  Aspiration treatment of perforated ulcers. A further report.

Authors:  H TAYLOR
Journal:  Lancet       Date:  1951-01-06       Impact factor: 79.321

7.  Conservative management of perforated duodenal ulcer.

Authors:  T E Keane; B Dillon; N H Afdhal; C J McCormack
Journal:  Br J Surg       Date:  1988-06       Impact factor: 6.939

8.  Selective treatment of duodenal ulcer with perforation.

Authors:  A J Donovan; T L Vinson; G O Maulsby; J R Gewin
Journal:  Ann Surg       Date:  1979-05       Impact factor: 12.969

9.  A randomized trial of nonoperative treatment for perforated peptic ulcer.

Authors:  T J Crofts; K G Park; R J Steele; S S Chung; A K Li
Journal:  N Engl J Med       Date:  1989-04-13       Impact factor: 91.245

  9 in total
  2 in total

1.  Perforated duodenal ulcer in high risk patients: is percutaneous drainage justified?

Authors:  Aly Saber; Mohammad A Gad; Gouda M Ellabban
Journal:  N Am J Med Sci       Date:  2012-01

Review 2.  Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference.

Authors:  Massimo Sartelli; Fausto Catena; Fikri M Abu-Zidan; Luca Ansaloni; Walter L Biffl; Marja A Boermeester; Marco Ceresoli; Osvaldo Chiara; Federico Coccolini; Jan J De Waele; Salomone Di Saverio; Christian Eckmann; Gustavo P Fraga; Maddalena Giannella; Massimo Girardis; Ewen A Griffiths; Jeffry Kashuk; Andrew W Kirkpatrick; Vladimir Khokha; Yoram Kluger; Francesco M Labricciosa; Ari Leppaniemi; Ronald V Maier; Addison K May; Mark Malangoni; Ignacio Martin-Loeches; John Mazuski; Philippe Montravers; Andrew Peitzman; Bruno M Pereira; Tarcisio Reis; Boris Sakakushev; Gabriele Sganga; Kjetil Soreide; Michael Sugrue; Jan Ulrych; Jean-Louis Vincent; Pierluigi Viale; Ernest E Moore
Journal:  World J Emerg Surg       Date:  2017-05-04       Impact factor: 5.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.